worry about the future, and guilt at the risk of transmission to their children were described. Many subjects (10/25) said that the worst aspect ofMD is the risk oftransmission to their children. Over half (14/25) said that the risk of transmitting MD had influenced or would influence their own reproduction. Three-quarters of subjects who felt that MD had influenced their reproductive decisions (9/12) chose to limit their family or have no children; only 25% (3/12) requested PND. Subjects felt that the lack of information concerning clinical severity made PND for MD difficult to consider.
Myotonic dystrophy (MD) is a progressive, autosomal dominant condition with extreme phenotypic variability. It is the most common muscular dystrophy of adult life with a prevalence estimated at 2.4-5.5 per 100 000.' The disease is characterised by myotonia associated with muscle weakness and wasting; however, affected subjects can Three subjects from two families had been aware since childhood that MD affected their family and had grown up with some knowledge of the "family illness". For the remaining 22 subjects from 17 families, the family diagnosis was made 3-21 years before interview (mean 9.5 years). The majority of affected women interviewed (13/25) had been investigated on account of known family history; however, four (16%) presented with symptoms and five (20%) were diagnosed after giving birth to a congenitally affected child. Subjects' own diagnoses occurred 3-21 years before interview (mean 9.8 years). On average, subjects were aware of five living affected subjects within their extended family (range 2-12). Information was also gathered on subjects' occupation and religious preference but in this small study there was no obvious relationship between these variables, knowledge of MD, or reproductive decisions and so these data are not presented here.
CLINICAL AND GENETIC KNOWLEDGE
When asked to name some of the signs and symptoms of MD all subjects (n=25) mentioned muscle weakness, 80% (20/25) mentioned myotonia, and 76% (19/25) said cataracts (table 1) . Other signs and symptoms were less well known and tended to reflect subjects' own or family experience. Only a third of subjects (8/25) appeared aware of the risk of anaesthetic complications associated with MD. 4 16 Endocrine anomalies 3 12 Auditory problems 2 8 Complications in pregnancy 2 8 Impaired memory 2 8 Other 2 8 (fig 1) . The possible implications of these observations will be explored more fully in the discussion.
PERSONAL AND FAMILY EXPERIENCE
Subjects were asked how they had felt at the time of their diagnosis. Three women (12%) said that they were "devastated" and a further seven subjects (28%) used similar emotive language including "stunned", "worried", "upset", "guilty", and "depressed". Diagnosis was particularly difficult when it occurred after the birth of a congenitally affected child (5/25). One subject said "I could not understand why they were doing so many tests on me when the baby was so sick". Two subjects described feelings of intense guilt that they had been the cause of their baby's problems. Mildly affected subjects who had not given birth to a congenitally affected child appeared to have less difficulty coping with the diagnosis, although some expressed feelings of confusion. Six subjects (24%) found it difficult to accept that they had a medical condition of which they had been unaware. One woman said that she had always experienced myotonia of grip but had simply "pulled her fingers straight" and thought no more of it. In common with other studies8 subjects often wished to talk at length about the time of diagnosis, with concerns about their own prognosis and feelings of guilt regarding the risk of transmission to children being major themes.
When asked if they felt MD had affected them severely, moderately, or mildly, two women (8%) said severely, 10 (40%) said moderately, and 13 (52%) said mildly. Ten subjects (40%) described restrictions in daily life brought about by physical symptoms of the condition. This included needing help with the housework and shopping, finding it difficult to get out of the house, and suffering from lethargy. Seven subjects (28%) had particular worries about the future in terms of the health of affected family members, the risk of transmission to children, and the restrictions MD placed on normal family life. Six subjects (24%) felt that MD had not affected them significantly and two subjects (8%) said they "just adapted" and "got on with life". Seventeen subjects (68%) felt that they might consider PND themselves in a future pregnancy, but only 9/25 (36%) felt they would consider termination if the child was shown to have inherited MD. In general, women were interested in "preparing" themselves but felt unhappy about termination in the absence of reliable information about clinical severity. Twenty-three subjects (92%) felt a prenatal test which could give reliable information about clinical severity would be an improvement and 19 (76%) said that they would consider such a test themselves. All of these women said that they would consider terminating a severely affected pregnancy.
Discussion
Kessler"2 suggested that information given within a genetic counselling session is not absorbed in isolation but integrated with previously stored information and experiences. In this study, subjects' knowledge of MD was generally good and related to their own or family experience. Almost all subjects were aware of the main symptoms of MD, its inherited basis, and its variable but progressive nature. Subjects with more affected relatives, those who perceived themselves to be more severely affected, and those with more affected children appeared more knowledgeable about the condition. It seems likely that subjects with more affected relatives/children will have greater first hand experience of MD and will therefore be more knowledgeable. The relationship between knowledge and number of congenitally affected children was particularly striking and may reflect subjects' concern for their offspring as well some possible feelings of guilt about passing the gene on. In view of the intellectual impairment which can be part of the clinical picture in subjects who are more severely affected, it might be expected that subjects who are classified medically as moderately to severely affected could actually be less know-ledgeable about the condition, despite having more "first hand experience". It is also possible that subjects with greater knowledge perceive themselves to be more severely affected whereas subjects with less knowledge are less concerned. It would be necessary to compare a medical classification of severity with subjects' own views in order to investigate this further. In their study of patients and families with NFI, Benjamin et at found no correlation between subjects' perception of severity and medical classification based on clinical features. A person's perception of the "burden" of genetic disease is likely to reflect psychological areas of concern as well as clinical symptoms of the condition.
Just over half of the subjects (56%, n=14) were able to give the correct risk of transmission to their children, somewhat less than in other studies.9 '3 Poor or inaccurate recall of information after genetic counselling has been reported by other researchers'4 '5 and it is possible that the clinical variability of MD, anticipation, and the maternal transmission of CMD makes it more difficult for subjects to conceptualise the risk of transmission. Anxiety over the risk of CMD may also lead subjects to have a more pessimistic viewpoint and in this study there was a tendency for subjects to overestimate rather than underestimate the risk. A number of the subjects interviewed would have received most of their genetic counselling before the discovery of the genetic mechanism underlying MD. This may account for some of their "lack" of knowledge and may explain much of the confusion surrounding anticipation and maternal transmission of CMD. The detailed information about genetic aspects of MD needs to be presented clearly to aid good understanding by affected subjects; however, recall of genetic "facts" is likely to be complex and not simply related to the clarity of presentation. Summary letters, reinforcement counselling, information leaflets, and continued follow up may be beneficial particularly in facilitating access to genetic counselling services. It is likely that people's circumstances and therefore their ability to integrate aspects of genetic information will change with time. Maintaining contact and the offer of continuing follow up and support is one of the aims of the NWRGFR.
In agreement with other studies on the impact of genetic conditions,89 16 This was a small, qualitative study intended to gain insight into the burden of a variable condition and a larger sample group would be needed to allow more complex statistical analysis and estimates of significance. The women included in this study may be more severely affected and have more experience of MD than a group of affected women not ascertained from the NWRGFR. Nevertheless, results from this study give an appreciation of the understanding and concerns of a group of women with myotonic dystrophy and highlight areas of interest both for possible future research and for counselling affected subjects. 
